United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

wockhardt uk ltd - sodium valproate - oral solution - 40mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

wockhardt uk ltd - sodium valproate - gastro-resistant tablet - 500mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

wockhardt uk ltd - sodium valproate - gastro-resistant tablet - 200mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

wockhardt uk ltd - sodium valproate - solution for injection - 100mg/1ml

European Union - English - EMA (European Medicines Agency)

merck sharp & dohme b.v.  - imipenem monohydrate, cilastatin sodium, relebactam monohydrate - gram-negative bacterial infections - carbapenems, antibacterials for systemic use, - recarbrio is indicated for:- treatment of hospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap), in adults (see sections 4.4 and 5.1).- treatment of bacteraemia that occurs in association with, or is suspected to be associated with hap or vap, in adults.- treatment of infections due to aerobic gram-negative organisms in adults with limited treatment options (see sections 4.2, 4.4, and 5.1).consideration should be given to official guidance on the appropriate use of antibacterial agents.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - sodium valproate -

Philippines - English - FDA (Food And Drug Administration)

pharma-surrey international, inc.; distributor: pharma-surrey international, inc. - imipenem (as monohydrate) , cilastatin (as sodium) - powder for injection (iv) - 500mg/500mg

Philippines - English - FDA (Food And Drug Administration)

bio care medical co. - imipenem (as monohydrate) , cilastatin (as sodium) - powder for i.v. infusion - 500mg/ 500mg

Philippines - English - FDA (Food And Drug Administration)

jazmark pharmaceutical - imipenem (as monohydrate) , cilastatin (as sodium) - powder for injection (iv) - 500mg + 500mg

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - sodium valproate, quantity: 500 mg - tablet, enteric coated - excipient ingredients: citric acid monohydrate; hypromellose; polyvinyl acetate phthalate; diethyl phthalate; purified talc; hyprolose; titanium dioxide; povidone; magnesium stearate; amaranth aluminium lake; calcium silicate; indigo carmine aluminium lake; stearic acid; macrogol 6000 - epilepsy: primary generalised epilepsy (petit mal absences, various forms of myoclonic epilepsy and tonic-clonic grand mal seizures). partial (focal) epilepsy either alone or as adjuvant therapy. mania: for the treatment of mania where other therapy has proved inadequate or is inappropriate